{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:04Z","timestamp":1777865224087,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2016-76083-R"],"award-info":[{"award-number":["SAF2016-76083-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["CTQ2015-64425-C2-1-R"],"award-info":[{"award-number":["CTQ2015-64425-C2-1-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["RTI2018-097210-B-I00"],"award-info":[{"award-number":["RTI2018-097210-B-I00"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01287"],"award-info":[{"award-number":["PI18\/01287"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PGC2018-094503-B-C22"],"award-info":[{"award-number":["PGC2018-094503-B-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0123-2018"],"award-info":[{"award-number":["PI-0123-2018"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111604","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:33:37Z","timestamp":1565267617000},"page":"111604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies"],"prefix":"10.1016","volume":"182","author":[{"given":"Elena M.","family":"S\u00e1nchez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Isabel","family":"Garc\u00eda-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Arroba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Aguilar-Diosdado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7488-1774","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Fustero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-8393","authenticated-orcid":false,"given":"Jos\u00e9-Emilio","family":"S\u00e1nchez-Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-508X","authenticated-orcid":false,"given":"Laura","family":"Masgrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7676-7721","authenticated-orcid":false,"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111604_bib1","first-page":"529","article-title":"KRN7000, a novel immunomodulator, and its antitumor activities","volume":"7","author":"Kobayashi","year":"1995","journal-title":"Oncol. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of v\u03b114 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111604_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001412","article-title":"The molecular basis for recognition of CD1d\/\u03b1-galactosylceramide by a human non-V\u03b124 T cell receptor","volume":"10","author":"L\u00f3pez-Sagaseta","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2019.111604_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2019.111604_bib5","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1039\/c0ob00975j","article-title":"The stimulating adventure of KRN 7000","volume":"9","author":"Banchet-Cadeddu","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.14","article-title":"Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents","volume":"5","author":"Carre\u00f1o","year":"2016","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.ejmech.2019.111604_bib7","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/chem.201601539","article-title":"Small-molecule carbohydrate-based immunostimulants","volume":"23","author":"Marzabadi","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.111604_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ejmech.2017.10.015","article-title":"Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics","volume":"143","author":"Govindarajan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib9","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1021\/ja062740z","article-title":"Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity","volume":"128","author":"Fujio","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111604_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/jm061243q","article-title":"Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant \u03b1-GalCer","volume":"50","author":"Lee","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib11","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jo100366v","article-title":"One-pot syntheses of immunostimulatory glycolipids","volume":"75","author":"Schombs","year":"2010","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00044-017-2049-9","article-title":"Design, synthesis, and cytotoxicity evaluation of threonine-based galactoceramide with aromatic groups and various fatty-acyl side chains","volume":"27","author":"Vudhgiri","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1172\/JCI200420862","article-title":"The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells","volume":"113","author":"Oki","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2019.111604_bib14","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/ol8019555","article-title":"The first synthesis of a thioglycoside analogue of the immunostimulant KRN7000","volume":"10","author":"Dere","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2567.2008.02943.x","article-title":"Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells","volume":"127","author":"Li","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2019.111604_bib16","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1016\/j.tetlet.2011.07.103","article-title":"Synthesis of \u03b1-S-galactosylceramides with a truncated sphingoid chain","volume":"52","author":"Zhu","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.orglett.5b03591","article-title":"Lewis acid induced anomerization of Se-glycosides. Application to synthesis of \u03b1-Se-GalCer","volume":"18","author":"McDonagh","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.carres.2017.05.022","article-title":"Synthesis of a glucosylated \u03b1-S-galactosylceramide as potential immunostimulant","volume":"448","author":"Zhang","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/glycob\/cwy035","article-title":"Novel thioglycoside analogs of \u03b1-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells","volume":"28","author":"Melo","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2019.111604_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.carres.2017.03.005","article-title":"Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues","volume":"443\u2013444","author":"Altiti","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1021\/ar050006z","article-title":"\u03b1-C-Galactosylceramides: Synthesis and immunology","volume":"39","author":"Franck","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/cmdc.200900193","article-title":"Aminocyclitol-substituted phytoceramides and their effects on iNKT cell stimulation","volume":"4","author":"Harrak","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111604_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acsmedchemlett.5b00046","article-title":"Synthesis and biological activities of 5-Thio-\u03b1-GalCers","volume":"6","author":"Bi","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acsmedchemlett.7b00107","article-title":"Efficient divergent synthesis of new immunostimulant 4\u2033-modified \u03b1-galactosylceramide analogues","volume":"8","author":"Janssens","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cjoc.201600862","article-title":"Synthesis of iminosugar-containing KRN7000 analogues","volume":"35","author":"Zhang","year":"2017","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib26","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.4049\/jimmunol.1103049","article-title":"Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties","volume":"188","author":"Kerzerho","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111604_bib27","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1021\/ja202610x","article-title":"Galacto-configured aminocyclitol phytoceramides are potent in\u00a0vivo invariant natural killer T cell stimulators","volume":"133","author":"Harrak","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111604_bib28","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.bcp.2007.03.006","article-title":"A\u00a0synthetic analog of \u03b1-galactosylceramide induces macrophage activation via the TLR4-signaling pathways","volume":"73","author":"Hung","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111604_bib29","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.18632\/oncotarget.7315","article-title":"CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2019.111604_bib30","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1039\/c0ob00990c","article-title":"Synthesis of serine-based glycolipids as potential TLR4 activators","volume":"9","author":"Huang","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib31","doi-asserted-by":"crossref","first-page":"43782","DOI":"10.1074\/jbc.M111.285171","article-title":"In\u00a0vitro and in\u00a0vivo anticancer activity of a synthetic glycolipid as toll-like receptor 4 (TLR4) activator","volume":"286","author":"Lin","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087030","article-title":"Anti-inflammatory effects of \u03b1-galactosylceramide analogs in activated microglia: involvement of the p38 MAPK signaling pathway","volume":"9","author":"Jeong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111604_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.13.7.787","article-title":"The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine\/threonine kinase, Akt","volume":"13","author":"Gills","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2019.111604_bib34","doi-asserted-by":"crossref","first-page":"27020","DOI":"10.1074\/jbc.M701108200","article-title":"Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38\u03b1, through MKK3\/6-independent and -dependent mechanisms","volume":"282","author":"Gills","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib35","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.bbalip.2016.09.001","article-title":"d-3-deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway","volume":"1861","author":"Gradziel","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.111604_bib36","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-03-1530","article-title":"Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed ether lipid analogues","volume":"64","author":"Castillo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib37","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1039\/c0cc00446d","article-title":"Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral \u03b1-glucosidase inhibitory activity as antitumour agents","volume":"46","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111604_bib38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1039\/a705755e","article-title":"N-Thiocarbonyl azasugars: a new family of carbohydrate mimics with controlled anomeric configuration","volume":"0","author":"Jim\u00e9nez Blanco","year":"1997","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111604_bib39","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1039\/c1ob05234a","article-title":"Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards \u03b2-glucocerebrosidase","volume":"9","author":"Aguilar-Moncayo","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/mt.2012.263","article-title":"A\u00a0bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis","volume":"21","author":"Takai","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2019.111604_bib41","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1002\/anie.201505147","article-title":"pH-Responsive pharmacological chaperones for rescuing mutant glycosidases","volume":"54","author":"Mena-Barrag\u00e1n","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111604_bib42","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111604_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2015.08.038","article-title":"Inhibitor versus chaperone behaviour of D-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: a structure-activity relationship study in Gaucher fibroblasts","volume":"121","author":"Mena-Barrag\u00e1n","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ejmech.2015.10.038","article-title":"Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp2-iminosugar conjugates: novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme","volume":"121","author":"de la Fuente","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/molecules23040927","article-title":"Probing the inhibitor versus chaperone properties of sp2-Iminosugars towards human \u03b2-glucocerebrosidase: a picomolar chaperone for Gaucher disease","volume":"23","author":"Mena-Barrag\u00e1n","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111604_bib46","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbadis.2016.05.024","article-title":"Modulation of microglia polarization dynamics during diabetic retinopathy in db\/db mice","volume":"1862","author":"Arroba","year":"2016","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2019.111604_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.02.078","article-title":"sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide-mediated human dendritic cell activation in\u00a0vitro and of acute inflammation in mice in\u00a0vivo","volume":"169","author":"Schaeffer","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fct.2017.11.050","article-title":"The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants","volume":"111","author":"Alcalde-Est\u00e9vez","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111604_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jmb.2012.10.007","article-title":"Lipid molecules induce p38\u03b1 activation via a novel molecular switch","volume":"424","author":"Tzarum","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111604_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076411","article-title":"New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells","volume":"8","author":"Allan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111604_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.carres.2016.01.006","article-title":"Influence of the configurational pattern of sp2-iminosugar pseudo N-, S-, O- and C-glycosides on their glycoside inhibitory and antitumor properties","volume":"429","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib52","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/jcp.25832","article-title":"sp2-Iminosugar \u03b1-glucosidase inhibitor 1-C-octyl-2-oxa-3-oxocastanospermine specifically affected breast cancer cell migration through Stim1, \u03b21-integrin, and FAK signaling pathways","volume":"232","author":"Gueder","year":"2017","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.111604_bib53","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1039\/C5RA02627J","article-title":"Antileishmanial activity of sp2-iminosugar derivatives","volume":"5","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111604_bib54","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kyung Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111604_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers10050131","article-title":"Insights of crosstalk between p53 protein and the MKK3\/MKK6\/p38 MAPK signaling pathway","volume":"10","author":"Stramucci","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2019.111604_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.str.2016.10.011","article-title":"Structural basis for the subversion of MAP kinase signaling by an intrinsically disordered parasite secreted agonist","volume":"25","author":"Pellegrini","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2019.111604_bib57","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4155\/fmc.15.5","article-title":"Polyfluorinated groups in medicinal chemistry","volume":"7","author":"Bassetto","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib59","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1021\/ja2045293","article-title":"Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the \u201chydrophobic wall\u201d of carbonic anhydrase","volume":"133","author":"Mecinovi\u0107","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111604_bib60","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1021\/acs.jmedchem.8b01222","article-title":"Reducing the lipophilicity of perfluoroalkyl groups by CF2\u2212F\/CF2\u2212Me or CF3\/CH3 Exchange","volume":"61","author":"Jeffries","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10545-011-9409-2","article-title":"Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB1 alleles causing GM1-gangliosidosis and Morquio B disease","volume":"35","author":"Fantur","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejmech.2019.111604_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.carres.2018.05.004","article-title":"Synthesis and glycosidase inhibition potency of all-trans substituted 1-C-perfluoroalkyl iminosugars","volume":"464","author":"Massicot","year":"2018","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.111604_bib63","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acs.jmedchem.6b01550","article-title":"Fluorinated chaperone\u2212\u03b2-cyclodextrin formulations for \u03b2-glucocerebrosidase activity enhancement in neuronopathic Gaucher disease","volume":"60","author":"Garc\u00eda-Moreno","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/acsmedchemlett.8b00640","article-title":"Synthesis of 5-thio-\u03b1-GalCer analogues with fluorinated acyl chain on lipid residue and their biological evaluation","volume":"10","author":"He","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib65","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.biochem.052208.114057","article-title":"Amphipols, nanodiscs, and fluorinated surfactants: three nonconventional approaches to studying membrane proteins in aqueous solutions","volume":"79","author":"Popot","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2019.111604_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/17476348.2.2.273","article-title":"Anti-inflammatory effects of perfluorocarbon compounds","volume":"2","author":"Lehmler","year":"2008","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.ejmech.2019.111604_bib67","article-title":"Perfluorocarbon reduces cell damage from blast injury by inhibiting signal paths of NF-\u03baB, MAPK and Bcl-2\/Bax signaling pathway in A549 cells","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111604_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cmdc.201700636","article-title":"A\u00a0comprehensive structural overview of p38\u03b1 mitogen activated protein kinase in complex with ATP-site and non-ATP-site binders","volume":"13","author":"Astolfi","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111604_bib69","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1002\/chem.201200279","article-title":"sp2-Iminosugar O-, S-, and N-glycosides as conformational mimics of \u03b1-linked disaccharides; implications for glycosidase inhibition","volume":"18","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2012","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.111604_bib70","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/ol901125n","article-title":"Generalized anomeric effect in gem-diamines: stereoselective synthesis of \u03b1-N-linked disaccharide mimics","volume":"11","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib71","doi-asserted-by":"crossref","first-page":"11722","DOI":"10.1021\/jo5025283","article-title":"Synthesis of multibranched australine derivatives from reducing castanospermine analogues through the Amadori rearrangement of gem-diamine intermediates: selective inhibitors of \u03b2-glucosidase","volume":"79","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib72","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1002\/chem.201700470","article-title":"The impact of heteromultivalency in lectin recognition and glycosidase inhibition: an integrated mechanistic study","volume":"23","author":"Garc\u00eda-Moreno","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.111604_bib73","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1021\/acs.jmedchem.9b00153","article-title":"Pharmacological chaperones for the treatment of \u03b1-mannosidosis","volume":"62","author":"R\u00edsquez-Cuadro","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/jo991242o","article-title":"Generalized anomeric effect in action:\u2009 synthesis and evaluation of stable reducing indolizidine glycomimetics as glycosidase inhibitors","volume":"65","author":"D\u00edaz P\u00e9rez","year":"2000","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib75","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1002\/ejoc.200500071","article-title":"Synthesis and comparative glycosidase inhibitory properties of reducing castanospermine analogues","author":"D\u00edaz P\u00e9rez","year":"2005","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib76","doi-asserted-by":"crossref","first-page":"16791","DOI":"10.1002\/chem.201303158","article-title":"Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect","volume":"19","author":"R\u00edsquez Cuadro","year":"2013","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.111604_bib77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ja.2009.53","article-title":"Gem-diamine 1-N-iminosugars as versatile glycomimetics: synthesis, biological activity and therapeutic potential","volume":"62","author":"Nishimura","year":"2009","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2019.111604_bib78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0040-4039(01)02218-3","article-title":"Convenient methods for the hydrolysis of oxazolidinones to vicinal aminoalcohols","volume":"43","author":"Katz","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib79","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1021\/ol401517x","article-title":"Stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), a new potent hexosaminidase inhibitor","volume":"15","author":"de la Fuente","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2019.111604_bib80","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1039\/C5OB00507H","article-title":"Stereoselective synthesis of 2-acetamido-1,2- dideoxynojirimycin (DNJNAc) and ureido-DNJNAc derivatives as new hexosaminidase inhibitors","volume":"13","author":"de la Fuente","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib81","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ejmech.2017.06.048","article-title":"New tacrine dimers with antioxidant linkers as dual drugs: anti-Alzheimer's and antiproliferative agents","volume":"138","author":"Rold\u00e1n-Pe\u00f1a","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003820","article-title":"Ex-vivo host and parasite response to antileishmanial drugs and immunomodulators","volume":"9","author":"Gonzalez-Fajardo","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111604_bib83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1134\/S0006297918030021","article-title":"Plasticity of human THP-1 cell phagocytic activity during macrophagic differentiation","volume":"83","author":"Kurynina","year":"2018","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.ejmech.2019.111604_bib84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2019.111604_bib85","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1167\/iovs.11-7736","article-title":"Microglia-mediated IGF-I neuroprotection in the rd10 mouse model of retinitis pigmentosa","volume":"52","author":"Arroba","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2019.111604_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biochi.2015.06.020","article-title":"Metabolic endotoxemia with obesity: is it real and is it relevant?","volume":"124","author":"Boutagy","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2019.111604_bib87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","article-title":"LPS induction of gene expression in human monocytes","volume":"13","author":"Guha","year":"2001","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.111604_bib88","first-page":"1895","article-title":"Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential","volume":"12","author":"Paine","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111604_bib89","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1021\/ma200367c","article-title":"Rapid access to polyfunctional lipids with complex architecture via oxyanionic ring-opening polymerization","volume":"44","author":"Hoffmann","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.ejmech.2019.111604_bib90","article-title":"Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation","volume":"5","author":"Orellana","year":"2016","journal-title":"Bio Protoc"},{"key":"10.1016\/j.ejmech.2019.111604_bib91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines","volume":"83","author":"Monks","year":"1991","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2019.111604_bib92","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01183-07","article-title":"Modulation of gene expression in human macrophages treated with the anti-Leishmania pentavalent antimonial drug sodium stibogluconate","volume":"52","author":"El Fadili","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111604_bib93","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.02481-13","article-title":"4-Amino bis-pyridinium derivatives as novel antileishmanial agents","volume":"58","author":"G\u00f3mez-P\u00e9rez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111604_bib94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2019.111604_bib95","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib96","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib97","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111604_bib98","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/jcc.24847","article-title":"GaudiMM: a modular multi-objective platform for molecular modelling","volume":"38","author":"Rodr\u00edguez-Guerra Pedregal","year":"2017","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.111604_bib99","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/acs.jcim.5b00654","article-title":"Better informed distance geometry: using what we know to improve conformation generation","volume":"55","author":"Riniker","year":"2015","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.111604_bib100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930738X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930738X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:58:17Z","timestamp":1777528697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930738X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":100,"alternative-id":["S022352341930738X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111604","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111604"}}